These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3396624)

  • 1. Comparison of the effect of irindalone, a novel serotonin 5-HT2 antagonist and ketanserin on mechanical responses of rat thoracic aorta.
    Mikkelsen EO; Nyborg NC; Jensen KT; Boeck V
    Eur J Pharmacol; 1988 Apr; 149(1-2):145-8. PubMed ID: 3396624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the stereoselective effects of a novel 5-HT2 receptor antagonist on contractile responses of rat aorta.
    Mikkelsen EO; Nielsen TJ; Nyborg NC
    Chirality; 1990; 2(4):226-8. PubMed ID: 2083144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urethane reduces contraction to 5-hydroxytryptamine (5-HT) and enhances the action of the 5-HT antagonist ketanserin on the rat thoracic aortic ring.
    Dringenberg HC; Vanderwolf CH; Hamilton JT
    J Neural Transm Gen Sect; 1995; 101(1-3):183-93. PubMed ID: 8695048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive activity in a series of 1-piperazino-3-phenylindans with potent 5-HT2-antagonistic activity.
    Bøgesø KP; Arnt J; Boeck V; Christensen AV; Hyttel J; Jensen KG
    J Med Chem; 1988 Dec; 31(12):2247-56. PubMed ID: 2903929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential antagonism of the initial fast and secondary slow contractile responses of the rat isolated aorta to 5-hydroxytryptamine by mianserin and ketanserin.
    Doggrell SA
    J Auton Pharmacol; 1987 Jun; 7(2):157-64. PubMed ID: 3654683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between Ca2+, verapamil, and ketanserin in rat tail artery and aorta.
    Okoro EO; Marwood JF; Stokes GS
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):603-10. PubMed ID: 7596129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of irindalone, a new S2-serotonergic antagonist, in the rat.
    Gradin K; Carlsson S; Hedner T; Persson B
    Pharmacol Toxicol; 1990 Sep; 67(3):199-204. PubMed ID: 2255675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of alpha 1-adrenoceptor antagonism of ketanserin on the nature of its 5-HT2 receptor antagonism.
    Marwood JF
    Clin Exp Pharmacol Physiol; 1994 Dec; 21(12):955-61. PubMed ID: 7736654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overlap in the pharmacology of L-type Ca2+-channel blockers and 5-HT2 receptor antagonists in rat aorta.
    Okoro EO
    J Pharm Pharmacol; 1999 Aug; 51(8):953-7. PubMed ID: 10504036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of serotonin receptors in isolated rat intramyocardial coronary artery.
    Lai FM; Tanikella T; Cervoni P
    J Pharmacol Exp Ther; 1991 Jan; 256(1):164-8. PubMed ID: 1988655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two different arterial tissues suggests possible 5-hydroxytryptamine2 receptor heterogeneity.
    Killam AL; Nikam SS; Lambert GM; Martin AR; Nelson DL
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1083-9. PubMed ID: 2319460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further analysis of the inhibitory effects of dihydroergotamine, cyproheptadine and ketanserin on the responses of the rat aorta to 5-hydroxytryptamine.
    Doggrell SA
    J Auton Pharmacol; 1992 Aug; 12(4):223-36. PubMed ID: 1512277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with irindalone in the spontaneously hypertensive rat.
    Gradin K; Hedner T; Persson B
    J Neural Transm Gen Sect; 1991; 83(3):227-33. PubMed ID: 1674420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiserotoninergic activity of 2-aminoethylbenzocyclanones in rat aorta: structure-activity relationships.
    Loza MI; Ferreiro TG; Sanz F; Lozoya E; Rodriguez J; Manaut F; Verde I; Castro E; Fontenla JA; Cadavid I
    J Pharm Sci; 1993 May; 82(5):513-7. PubMed ID: 8360829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of 5-HT2 receptors in serotonin-induced contraction in the human mammary artery.
    Conti A; Monopoli A; Forlani A; Ongini E; Antona C; Biglioli P
    Eur J Pharmacol; 1990 Feb; 176(2):207-12. PubMed ID: 2138088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketanserin potentiates the prejunctional inhibitory effect of 5-hydroxytryptamine on rat vas deferens.
    Moritoki H; Fukuda H; Kanaya J; Ishida Y
    J Pharm Pharmacol; 1986 Oct; 38(10):737-41. PubMed ID: 2878993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous inhibitory effect of nitrendipine on 5-HT-responses in rabbit vascular tissues.
    Gürdal H; Tulunay FC
    Gen Pharmacol; 1991; 22(6):1049-53. PubMed ID: 1810803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists.
    Feniuk W; Humphrey PP; Perren MJ; Watts AD
    Br J Pharmacol; 1985 Nov; 86(3):697-704. PubMed ID: 2933110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of propranolol on the contractions induced by noradrenaline, serotonin and CaCl2 in the isolated thoracic aorta of the rat].
    España MR; Orallo F; Cadavid I; Calleja JM
    Arch Farmacol Toxicol; 1986 Apr; 12(1):29-35. PubMed ID: 3740966
    [No Abstract]   [Full Text] [Related]  

  • 20. Modulation by 5-HT1A receptors of the 5-HT2 receptor-mediated tachykinin-induced contraction of the rat trachea in vitro.
    Germonpré PR; Joos GF; Pauwels RA
    Br J Pharmacol; 1998 Apr; 123(8):1571-8. PubMed ID: 9605563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.